Per Bengtson

knuten till universitetet
Fler filtreringsmöjligheter
  1. 2018
  2. Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation

    Vajro, P., Zielinska, K., Ng, B. G., Marco Maccarana, Per Bengtson, Poeta, M., Mandato, C., D'Acunto, E., Freeze, H. H. & Eklund, E. A., 2018 jan 10, I : Orphanet Journal of Rare Diseases. 13, 1, 4.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2016
  4. Phenotyping of α-1-Antitrypsin by liquid chromatography–high resolution mass spectrometry

    Per Bengtson, Valtonen-André, C. & Jonsson, M., 2016 dec 1, I : Clinical Mass Spectrometry. 2, s. 34-40

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Serum transferrin carrying the xeno-tetrasaccharide NeuAc-Gal-GlcNAc2 is a biomarker of ALG1-CDG.

    Per Bengtson, Ng, B. G., Jaeken, J., Matthijs, G., Freeze, H. H. & Eklund, E., 2016, I : Journal of Inherited Metabolic Disease. 39, 1, s. 107-114

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2015
  7. A fast semi-quantitative LC-MS method for measurement of intact apolipoprotein A-I reveals novel proteoforms in serum.

    Gåfvels, M. & Per Bengtson, 2015, I : Clinica Chimica Acta. 442, Jan 17, s. 87-95

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. A novel phenotype in N-glycosylation disorders: Gillessen-Kaesbach-Nishimura skeletal dysplasia due to pathogenic variants in ALG9.

    Tham, E., Eklund, E. A., Hammarsjö, A., Per Bengtson, Geiberger, S., Lagerstedt-Robinson, K., Malmgren, H., Nilsson, D., Grigelionis, G., Conner, P., Lindgren, P., Lindstrand, A., Wedell, A., Albåge, M., Zielinska, K., Nordgren, A., Papadogiannakis, N., Nishimura, G. & Grigelioniene, G., 2015, I : European Journal of Human Genetics.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2013
  10. Galectin-3 guides intracellular trafficking of some human serotransferrin glycoforms

    Carlsson, M., Per Bengtson, Cucak, H. & Hakon Leffler, 2013, I : Journal of Biological Chemistry. 288, 39, s. 28398-28408

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2009
  12. ScFv antibody-induced translocation of cell-surface heparan sulfate proteoglycan to endocytic vesicles: Evidence for heparan sulfate epitope specificity and role of both syndecan and glypican.

    Anders Wittrup, Zhang, S., Ten Dam, G. B., van Kuppevelt, T. H., Per Bengtson, Maria C Johansson, Welch, J., Mörgelin, M. & Mattias Belting, 2009, I : Journal of Biological Chemistry. 284, 47, s. 32959-32967

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2008
  14. Hypoxia-mediated induction of the polyamine system provides opportunities for tumor growth inhibition by combined targeting of vascular endothelial growth factor and ornithine decarboxylase.

    Svensson, K., Welch, J., Kucharzewska, P., Per Bengtson, Bjurberg, M., Sven Påhlman, Ten Dam, G. B., Lo Persson & Mattias Belting, 2008, I : Cancer Research. 68, 22, s. 9291-9301

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Single chain fragment anti-heparan sulfate antibody targets the polyamine transport system and attenuates polyamine-dependent cell proliferation.

    Welch, J. E., Per Bengtson, Svensson, K., Anders Wittrup, Jenniskens, G. J., Ten Dam, G. B., Van Kuppevelt, T. H. & Mattias Belting, 2008, I : International Journal of Oncology. 32, 4, s. 749-756

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift